Cynosure, Inc.  

(Public, NASDAQ:CYNO)   Watch this stock  
Find more results for CYNO
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 18.63 - 38.69
Open     -
Vol / Avg. 0.00/271,877.00
Mkt cap 791.14M
P/E 25.63
Div/yield     -
EPS 1.39
Shares 22.16M
Beta 1.32
Inst. own 87%
Jul 27, 2015
Q2 2015 Cynosure Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 5, 2015
Q1 2015 Cynosure Inc Earnings Release
May 5, 2015
Q1 2015 Cynosure Inc Earnings Call - Webcast
Mar 17, 2015
Cynosure Inc at Sidoti & Company Emerging Growth Research Institutional Investor Forum
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -0.01% 10.72%
Operating margin 2.74% 7.27%
EBITD margin - 22.47%
Return on average assets -0.01% 7.18%
Return on average equity -0.01% 9.13%
Employees 755 -
CDP Score - -


5 Carlisle Rd
WESTFORD, MA 01886-3601
United States - Map
+1-978-2564200 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cynosure Inc. (Cynosure develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis. The Company has also developed an aesthetic treatment product for the home use market. The Company’s product portfolio is composed of a range of energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. The Company offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. The Company’s product line includes, Elite, Affirm/SmartSkin, Cynergy and Accolade.

Officers and directors

Michael R. Davin Chairman of the Board, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Timothy W. Baker President, Chief Financial Officer, Chief Operating Officer, Treasurer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas J. Delaney Executive Vice President - Worldwide Sales
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William O. Flannery Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Brian M. Barefoot Independent Director
Age: 71
Bio & Compensation  - Reuters
Ettore V. Biagioni Independent Director
Age: 56
Bio & Compensation  - Reuters
Marina Hatsopoulos Independent Director
Age: 49
Bio & Compensation  - Reuters
Thomas H. Robinson Independent Director
Age: 56
Bio & Compensation  - Reuters